Neuroactive steroids, compositions, and uses thereof
US-2021403502-A1 · Dec 30, 2021 · US
Modified glucocorticoids
US12410209B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12410209-B2 |
| Application number | US-202117362440-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 29, 2021 |
| Priority date | Jun 29, 2021 |
| Publication date | Sep 9, 2025 |
| Grant date | Sep 9, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Certain embodiments are directed to modified glucocorticoid compounds having one or both of (i) a substitution of a halogen for the 11 hydroxy and/or (ii) reduction of the bond between carbon 4 and carbon 5 of the A ring.
First claim
Opening claim text (preview).
The invention claimed is: 1. A modified glucocorticoid compound of the following structure: or a pharmaceutically acceptable salt thereof. 2. A pharmaceutical composition comprising the compound of claim 1 .
Assignees
Inventors
Classifications
Antineoplastic agents · CPC title
- C07J7/009Primary
by only one oxygen atom doubly bound · CPC title
- C07J5/0053Primary
not substituted in position 16 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12410209B2 cover?
- Certain embodiments are directed to modified glucocorticoid compounds having one or both of (i) a substitution of a halogen for the 11 hydroxy and/or (ii) reduction of the bond between carbon 4 and carbon 5 of the A ring.
- Who is the assignee on this patent?
- Univ Texas
- What technology area does this patent fall under?
- Primary CPC classification C07J7/009. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).